作者
Gaetano Rocco,Giorgio Pennazza,Kay See Tan,Stijn Vanstraelen,Marco Santonico,Robert J Corba,Bernard J. Park,Smita Sihag,Matthew Bott,Pierfilippo Crucitti,James M. Isbell,Michelle S. Ginsberg,Hallie Weiss,Raffaele Antonelli Incalzi,Panaiotis Finamore,Filippo Longo,Alessandro Zompanti,Simone Grasso,Stephen B. Solomon,A. Vincent,A. McKnight,Michael A. Cirelli,Carmela Voli,Susan Kelly,Mario Merone,Daniela Molena,Katherine D. Gray,James Huang,Valerie W. Rusch,Manjit S. Bains,Robert J. Downey,Prasad S. Adusumilli,David R. Jones
摘要
Electronic nose (E-nose) technology has reported excellent sensitivity and specificity in the setting of lung cancer screening. However, the performance of E-nose specifically for early-stage tumors remains unclear. Therefore, the aim of our study was to assess the diagnostic performance of E-nose technology in clinical stage I lung cancer.